Information Technology Developer IT Developer Location: Watford (Hybrid 3 days office based and 2 days working from home) Salary: Competitive + Benefits Closing date: 31st July 2026 About Us At Corona Energy, we are proud to be one of
Information Technology Service Delivery Manager IT Service Delivery Manager Location: Watford (Hybrid 3 days office based and 2 days working from home) Salary: Competitive + Benefits Closing date: 31st July 2026 About Us At Corona Energy, we
Group Health & Safety Manager - London Salary: Company Description McArthurGlen Group, Europes leading owner, developer and manager of designer outlets, was founded in Europe in 1993 and currently manages 20+ designer outlets in 8 countries. Job
Partnership Manager - London Salary: 65000 Company Description McArthurGlen Group, Europes leading owner, developer and manager of designer outlets, was founded in Europe in 1993 and currently manages 20+ designer outlets in 8 countries. Job Description As
KYC Analyst - London Salary: 35000 Company Description McArthurGlen Group, Europes leading owner, developer and manager of designer outlets, was founded in Europe in 1993 and currently manages 20+ designer outlets in 8 countries. Job Description We
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs
Corporate Leasing Manager - London Salary: 45000 Company Description McArthurGlen Group, Europes leading owner, developer and manager of designer outlets, was founded in Europe in 1993 and currently manages 20+ designer outlets in 8 countries. Job Description
Manager, Quality Systems - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in